Advanced Micro Devices (AMD) Sold Off in Q4 Despite Strong Earnings
Investment advisory firm Ithaka Group released the “Ithaka US Growth Strategy” fourth-quarter 2024 investor letter. A copy of ...
Absci stock reiterated at Buy at H.C. Wainwright on AI-drug discovery leadership
H.C. Wainwright maintained a positive stance on Absci Corp (NASDAQ:ABSI), with an analyst from the firm reiterating a Buy rating and a price target of $7.00.